Brain natriuretic peptide: a potential marker for mortality in septic shock.

[1]  K. Werdan,et al.  Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction , 2003, Intensive Care Medicine.

[2]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[3]  G. Lamas,et al.  Brain natriuretic peptide and HIV-related cardiomyopathy. , 2002, The AIDS reader.

[4]  Anand Kumar,et al.  Clinical review: Myocardial depression in sepsis and septic shock , 2002, Critical care.

[5]  G. Lamas,et al.  Plasma Levels of Brain Natriuretic Peptide: A Potential Marker for HIV-Related Cardiomyopathy , 2002, Journal of cardiovascular pharmacology and therapeutics.

[6]  N. Žarković,et al.  Pro-atrial natriuretic peptide hormone from right atria is correlated with cardiac depression in septic patients , 2001, Journal of endocrinological investigation.

[7]  A. Kumar,et al.  Septic myocardial depression: no "no" to no? , 2001, Critical care medicine.

[8]  A. Groeneveld,et al.  alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. , 2001, Critical care medicine.

[9]  K. Bailey,et al.  Clinical criteria and biochemical markers for the detection of systolic dysfunction. , 2000, Journal of cardiac failure.

[10]  Y. Yazaki,et al.  Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels. , 2000, Japanese heart journal.

[11]  A. Groeneveld,et al.  a-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock , 2000 .

[12]  L Bordenave,et al.  Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. , 1999, The Journal of laboratory and clinical medicine.

[13]  B. Munt,et al.  Diastolic filling in human severe sepsis: an echocardiographic study. , 1998, Critical care medicine.

[14]  H. Tunstall-Pedoe,et al.  Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.

[15]  P. Poole‐Wilson,et al.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care , 1997, The Lancet.

[16]  C. Visser,et al.  Left ventricular systolic and diastolic function in septic shock , 1997, Intensive Care Medicine.

[17]  H. Itoh,et al.  Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. , 1994, Biochemical and biophysical research communications.

[18]  S. Lavine,et al.  Left ventricular diastolic function in sepsis. , 1990, Critical care medicine.

[19]  F. Ognibene,et al.  clinical investigations in critical care Right Ventricular Dysfunction and Dilatation , Similar to Left Ventricular Changes , Characterize the Cardiac Depression of Septic Shock in Humans * , 2006 .

[20]  F. Ognibene,et al.  Responses of left ventricular function in survivors and nonsurvivors of septic shock , 1989 .

[21]  J. Vincent,et al.  Right ventricular dysfunction in septic shock: assessment by measurements of right ventricular ejection fraction using the thermodilution technique , 1989, Acta anaesthesiologica Scandinavica.

[22]  J. Nauta,et al.  Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study. , 1988, American heart journal.

[23]  F. Ognibene,et al.  Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. , 1988, Chest.

[24]  D. Berman,et al.  Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study. , 1984, Journal of the American College of Cardiology.

[25]  J. Shelhamer,et al.  Profound but reversible myocardial depression in patients with septic shock. , 1984, Annals of internal medicine.